000 01689 a2200481 4500
005 20250517014016.0
264 0 _c20160425
008 201604s 0 0 eng d
022 _a1559-131X
024 7 _a10.1007/s12032-015-0486-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLiang, Fang
245 0 0 _aGPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
_h[electronic resource]
260 _bMedical oncology (Northwood, London, England)
_cMar 2015
300 _a49 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Movement
_xgenetics
650 0 4 _aCell Proliferation
_xgenetics
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGlycogen Synthase Kinase 3
_xgenetics
650 0 4 _aGlycogen Synthase Kinase 3 beta
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMice, Nude
650 0 4 _aPhosphatidylinositol 3-Kinases
_xmetabolism
650 0 4 _aProstatic Neoplasms
_xgenetics
650 0 4 _aProto-Oncogene Proteins c-akt
_xgenetics
650 0 4 _aReceptors, G-Protein-Coupled
_xgenetics
650 0 4 _aSignal Transduction
650 0 4 _aTOR Serine-Threonine Kinases
_xgenetics
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aYue, Junmin
700 1 _aWang, Junyong
700 1 _aZhang, Lijuan
700 1 _aFan, Rui
700 1 _aZhang, Hao
700 1 _aZhang, Qingsong
773 0 _tMedical oncology (Northwood, London, England)
_gvol. 32
_gno. 3
_gp. 49
856 4 0 _uhttps://doi.org/10.1007/s12032-015-0486-1
_zAvailable from publisher's website
999 _c24579938
_d24579938